AHNAK and urinary bladder carcinoma: Future studies are needed to characterize the biology function of the associations between mutations in SMGs or pathways and mutational signature activities to establish the potential of utilizing the mutated genes such as AHNAK as biomarkers for the clinical management of bladder cancer patients.